Literature DB >> 25752278

Cardiovascular disease: New nanomedicines for treating atherosclerotic plaques.

Jennifer Sargent.   

Abstract

Entities:  

Year:  2015        PMID： 25752278     DOI： 10.1038/nrendo.2015.35

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  2 in total

1.  Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.

Authors:  Daniel R Lewis; Latrisha K Petersen; Adam W York; Kyle R Zablocki; Laurie B Joseph; Vladyslav Kholodovych; Robert K Prud'homme; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

2.  Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice.

Authors:  Gabrielle Fredman; Nazila Kamaly; Stefano Spolitu; Jaclyn Milton; Devram Ghorpade; Raymond Chiasson; George Kuriakose; Mauro Perretti; Omid Farokzhad; Ira Tabas
Journal:  Sci Transl Med       Date:  2015-02-18       Impact factor: 17.956
  2 in total
  4 in total

Review 1.  Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases.

Authors:  Christos Tapeinos; Matteo Battaglini; Gianni Ciofani
Journal:  J Control Release       Date:  2017-08-26       Impact factor: 9.776

2.  Laminin Receptor-Avid Nanotherapeutic EGCg-AuNPs as a Potential Alternative Therapeutic Approach to Prevent Restenosis.

Authors:  Menka Khoobchandani; Kavita Katti; Adam Maxwell; William P Fay; Kattesh V Katti
Journal:  Int J Mol Sci       Date:  2016-03-01       Impact factor: 5.923

Review 3.  Nanomedicine applications in women's health: state of the art.

Authors:  Oliver Lloyd-Parry; Charlotte Downing; Eisa Aleisaei; Celine Jones; Kevin Coward
Journal:  Int J Nanomedicine       Date:  2018-03-29

4.  Cellular Interactions of Liposomes and PISA Nanoparticles during Human Blood Flow in a Microvascular Network.

Authors:  Mai N Vu; Hannah G Kelly; Adam K Wheatley; Scott Peng; Emily H Pilkington; Nicholas A Veldhuis; Thomas P Davis; Stephen J Kent; Nghia P Truong
Journal:  Small       Date:  2020-06-25       Impact factor: 15.153
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.